Showing 1 - 4 results of 4 for search 'Danqing Kong', query time: 0.02s
Refine Results
-
1
Efficacy and safety of chimeric antigen receptor T cell therapy in relapsed/refractory diffuse large B-cell lymphoma with different HBV status: a retrospective study from a single... by Danqing Kong, Danqing Kong, Nana Ping, Nana Ping, Xin Gao, Rui Zou, Peng Wang, Peng Wang, Depei Wu, Depei Wu, Zhengming Jin, Zhengming Jin, Changju Qu, Changju Qu
Published 2023-05-01
Article -
2
-
3
Decitabine-primed tandem CD19/CD22 CAR-T therapy in relapsed/refractory diffuse large B-cell lymphoma patients by Changju Qu, Changju Qu, Rui Zou, Rui Zou, Rui Zou, Peng Wang, Peng Wang, Qian Zhu, Qian Zhu, Liqing Kang, Liqing Kang, Nana Ping, Nana Ping, Fan Xia, Hailing Liu, Danqing Kong, Danqing Kong, Lei Yu, Lei Yu, Depei Wu, Depei Wu, Zhengming Jin, Zhengming Jin
Published 2022-08-01
Article -
4
P1089: ZANUBRUTINIB-RITUXIMAB CHEMO-FREE THERAPY WITH OR WITHOUT AUTOLOGOUS STEM CELL TRANSPLANTATION IN NEWLY DIAGNOSED MANTLE CELL LYMPHOMA by Chang-Ju Qu, Rui Zou, Jia-Jie He, Na-Na Ping, Qian Zhu, Xiao Zhang, Fan Xia, Danqing Kong, De-Pei Wu, Zheng-Ming Jin
Published 2023-08-01
Article